805 results on '"Bassaganya-Riera, Josep"'
Search Results
2. Goals in Nutrition Science 2020-2025
3. Goals in Nutrition Science 2020-2025.
4. Computational modeling of complex bioenergetic mechanisms that modulate CD4+ T cell effector and regulatory functions
5. Solving Immunology?
6. Development of Synthetic Patient Populations and In Silico Clinical Trials
7. From Nutritional Immunology to Drug Development
8. Preclinical Studies: Efficacy and Safety
9. Computer-Aided Drug Discovery
10. Introduction to Accelerated Path to Cures and Precision Medicine in Inflammatory Bowel Disease
11. Treating Autoimmune Diseases With LANCL2 Therapeutics: A Novel Immunoregulatory Mechanism for Patients With Ulcerative Colitis and Crohn's Disease.
12. Treating Autoimmune Diseases With LANCL2 Therapeutics: A Novel Immunoregulatory Mechanism for Patients With Ulcerative Colitis and Crohn’s Disease
13. S1078 Transcriptional Analysis of Colonic Biopsies From Patients With Ulcerative Colitis Treated With Omilancor
14. S1076 Efficacy and Safety of Omilancor in a Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial of Patients With Crohn’s Disease
15. S1077 Efficacy and Safety of Omilancor in a Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial of Patients With Ulcerative Colitis
16. First-in-class topical therapeutic omilancor ameliorates disease severity and inflammation through activation of LANCL2 pathway in psoriasis
17. Oral Omilancor Treatment Ameliorates Clostridioides difficile Infection During IBD Through Novel Immunoregulatory Mechanisms Mediated by LANCL2 Activation.
18. Host metabolic reprogramming ameliorates disease severity and colitis during Clostridioides difficileinfection
19. Blockade of IL-18 signaling downregulates homing of effector CD4+ T cells to the gut mucosa and provides protection from experimental IBD
20. Activation of PHACTR2 with oral NIM-1001 treatment enhances regulatory CD4+ T cell function and provides protection from systemic lupus erythematosus
21. The M2 Pipeline: A Novel Tool for Rapidly Analyzing Host Metabolic Profiles from RNA-seq Data
22. Modeling new immunoregulatory therapeutics as antimicrobial alternatives for treating Clostridium difficile infection
23. Identification of new regulatory genes through expression pattern analysis of a global RNA-seq dataset from a Helicobacter pylori co-culture system
24. Abscisic acid enriched fig extract promotes insulin sensitivity by decreasing systemic inflammation and activating LANCL2 in skeletal muscle
25. The Safety, Tolerability, and Pharmacokinetics Profile of BT-11, an Oral, Gut-Restricted Lanthionine Synthetase C-Like 2 Agonist Investigational New Drug for Inflammatory Bowel Disease: A Randomized, Double-Blind, Placebo-Controlled Phase I Clinical Trial
26. Reconstruction of endosomal organization and function by a combination of ODE and agent-based modeling strategies
27. Activation of LANCL2 by BT-11 Ameliorates IBD by Supporting Regulatory T Cell Stability Through Immunometabolic Mechanisms
28. Correction to: Efficacy, Safety, and Tolerability of Omilancor in a Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial of Patients With Ulcerative Colitis
29. Novel Screening Tool for Stroke Using Artificial Neural Network
30. Expression of PPAR γ in intestinal epithelial cells is dispensable for the prevention of colitis by dietary abscisic acid
31. Conjugated linoleic acid modulates immune responses in patients with mild to moderately active Crohn's disease
32. Pharmacophore modeling improves virtual screening for novel peroxisome proliferator-activated receptor-gamma ligands
33. LABP-73: A Novel NLRX1 Ligand for the Treatment of Chronic Asthma
34. WITHDRAWN: EFFICACY, SAFETY, AND TOLERABILITY OF OMILANCOR IN A PHASE 2 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF PATIENTS WITH ULCERATIVE COLITIS
35. Ordinary Differential Equations (ODEs) Based Modeling
36. Immunoinformatics Cyberinfrastructure for Modeling and Analytics
37. Use of Computational Modeling in Immunological Research
38. Computational Modeling
39. Introduction to Computational Immunology
40. Modeling Exercises
41. List of Contributors
42. Agent-Based Modeling and High Performance Computing
43. From Big Data Analytics and Network Inference to Systems Modeling
44. Multiscale Modeling
45. Genetics and molecular specificity of sialylation of Histophilus somni lipooligosaccharide (LOS) and the effect of LOS sialylation on Toll-like receptor-4 signaling
46. Nlrx1-Regulated Defense and Metabolic Responses to Aspergillus fumigatus Are Morphotype and Cell Type Specific
47. Enemy of My Enemy: A Novel Insect-Specific Flavivirus Offers a Promising Platform for a Zika Virus Vaccine
48. Supervised Learning with the Artificial Neural Networks Algorithm for Modeling Immune Cell Differentiation
49. Contributors
50. Abscisic acid ameliorates atherosclerosis by suppressing macrophage and CD4 + T cell recruitment into the aortic wall
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.